e-Book
While passive cardiovascular implants might look simple on the outside, they are challenging to develop, manufacture, and implant. These devices must function under different physiological conditions while sustaining performance throughout their intended life cycle and work for a variety of patient demographics. They also must undergo rigorous regulatory approval before reaching the market.
With so many variables, it is easy for production and regulatory approval processes to be delayed, which ultimately postpones access to these lifesaving devices for those who need them most. Computational modeling and simulation (CM&S) offers a solution to address these challenges by enabling medical device manufacturers to accelerate product development and approval while reducing uncertainty and maintaining safety.
Read the e-book to learn how in silico solutions address some of the most common challenges manufacturers face while developing passive cardiovascular devices.
SHARE THIS E-BOOK
讓我們開始吧
如果您面臨工程挑戰，我們的團隊將隨時為您提供協助。憑藉豐富的經驗和對創新的承諾，我們邀請您與我們聯絡。讓我們共同合作，將您的工程障礙轉化為成長和成功的機會。立即與我們聯絡，開始對話。